{
    "nctId": "NCT00268125",
    "briefTitle": "Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.",
    "officialTitle": "Evaluation of Acupression's Bracelets Associated to an Educational Step Versus Education Only in Nausea and Vomiting's Mastering Induced by FEC100 Chemotherapy's Sort.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 347,
    "primaryOutcomeMeasure": "Reduction of 15% of stage III/IV nausea and vomiting's incidence.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Woman\n* Age \\> 18 years\n* Well-informed written consent, signed by the patient before the beginning of the study\n* Breast cancer's diagnosis (operated or not)\n* Forecast of a treatment by FEC100 chemotherapy's sort (D1=D21) during at least 3 cycles.\n* Patient affiliated at a welfare or beneficiary from it\n* Investigator estimates that the patient is able to conform with protocol's conditions and to respect them\n\nExclusion Criteria:\n\n* Operated arm's lymphedema\n* Wrist's morphology which cannot permit the bracelet's wearing (20 cm)\n* D1=D15 FEC100's treatment\n* Psychic incapability to sign a well-informed consent\n* Refusal to give a written consent\n* Patient under tutelage or guardianship\n* Pregnant or breast-feeding woman\n* Any clinical trial's participation which would impose nausea and vomiting's treatment modalities",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}